Adial Pharmaceuticals Inc (ADIL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ADIL | BMY | AMGN | GILD | MRNA |
| Company | Adial Pharmaceuticals Inc | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Moderna Inc |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 1.4700 | 76.50 | 244.06 | 63.37 | 143.07 |
| High | 1.4700 | 77.15 | 247.66 | 63.90 | 144.77 |
| Low | 1.3400 | 75.34 | 242.96 | 62.72 | 131.35 |
| Last | 1.3600 | 76.19 | 247.50 | 63.84 | 136.25 |
| Change | -0.0100 | +0.23 | +2.73 | +0.57 | -7.13 |
| % Change | -0.73% | +0.30% | +1.12% | +0.90% | -4.97% |
| Volume | 71,200 | 17,329,600 | 3,860,500 | 6,814,500 | 5,882,500 |
| 20-Day Average Volume | 114,325 | 16,141,935 | 3,455,975 | 8,657,595 | 6,845,075 |
| Previous Close | 1.3700 | 75.96 | 244.77 | 63.27 | 143.38 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.3865 | 76.22 | 241.32 | 61.84 | 139.56 |
| 20-Day Raw Stochastic | 42.32% | 55.52% | 78.58% | 98.22% | 47.30% |
| 20-Day Relative Strength | 41.15% | 54.26% | 56.90% | 58.37% | 45.15% |
| Weighted Alpha | -58.80 | +20.60 | +4.60 | -7.50 | -36.10 |
| Today's Opinion | 100% Sell | 80% Buy | 72% Buy | 24% Sell | 100% Sell |
| Previous Opinion | 100% Sell | 80% Buy | 72% Buy | 40% Sell | 88% Sell |
| Last Month's Opinion | 100% Sell | 100% Buy | 100% Buy | 40% Sell | 88% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +6.25% since 05/13/22 | +0.51% since 05/13/22 | +1.68% since 05/13/22 | +2.36% since 05/13/22 | -1.20% since 05/13/22 |
| Low | 1.2200 on 05/18/22 | 75.34 on 05/20/22 | 239.26 on 05/17/22 | 61.80 on 05/17/22 | 131.35 on 05/20/22 |
| High | 1.5500 on 05/17/22 | 78.46 on 05/18/22 | 247.66 on 05/20/22 | 63.92 on 05/18/22 | 148.50 on 05/19/22 |
| 1-Month | |||||
| %Chg | -21.84% since 04/20/22 | -1.41% since 04/20/22 | -3.09% since 04/20/22 | +0.38% since 04/20/22 | -9.24% since 04/20/22 |
| Low | 1.1400 on 05/12/22 | 73.35 on 04/29/22 | 227.32 on 05/02/22 | 59.15 on 05/02/22 | 119.01 on 05/12/22 |
| High | 1.7800 on 04/21/22 | 78.46 on 05/18/22 | 258.39 on 04/21/22 | 64.28 on 04/21/22 | 155.46 on 05/04/22 |
| 3-Month | |||||
| %Chg | -33.66% since 02/18/22 | +12.79% since 02/18/22 | +12.11% since 02/18/22 | +4.57% since 02/18/22 | -6.51% since 02/18/22 |
| Low | 1.1400 on 05/12/22 | 66.19 on 02/24/22 | 214.39 on 02/24/22 | 57.19 on 03/16/22 | 119.01 on 05/12/22 |
| High | 2.2650 on 04/05/22 | 78.46 on 05/18/22 | 258.45 on 04/11/22 | 64.28 on 04/21/22 | 188.00 on 03/22/22 |
| 6-Month | |||||
| %Chg | -54.97% since 11/19/21 | +31.75% since 11/19/21 | +20.10% since 11/19/21 | -7.06% since 11/19/21 | -48.35% since 11/19/21 |
| Low | 1.1400 on 05/12/22 | 53.22 on 11/30/21 | 198.64 on 12/01/21 | 57.19 on 03/16/22 | 119.01 on 05/12/22 |
| High | 3.1400 on 11/24/21 | 78.46 on 05/18/22 | 258.45 on 04/11/22 | 74.12 on 12/30/21 | 376.65 on 11/29/21 |
| Key Statistics | |||||
| Market Capitalization, $K | 32,353 | 162,213,392 | 132,214,496 | 80,075,344 | 54,194,800 |
| Shares Outstanding, K | 23,789 | 2,129,064 | 534,200 | 1,254,313 | 397,760 |
| Annual Sales | 0 | 46,385,000,000 | 25,979,000,000 | 27,305,000,000 | 18,471,000,000 |
| Annual Net Income | -19,420,000 | 6,994,000,000 | 5,893,000,000 | 6,225,000,000 | 12,202,000,000 |
| Last Quarter Sales | 0 | 11,648,000,000 | 6,238,000,000 | 6,590,000,000 | 6,066,000,000 |
| Last Quarter Net Income | -2,907,839 | 1,278,000,000 | 1,476,000,000 | 19,000,000 | 3,657,000,000 |
| 60-Month Beta | 0.83 | 0.49 | 0.58 | 0.38 | 1.70 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.13 on 05/16/22 | 1.96 on 04/29/22 | 4.25 on 04/27/22 | 2.12 on 04/28/22 | 8.58 on 05/04/22 |
| Latest Earnings Date | 05/16/22 | 04/29/22 | 04/27/22 | 04/28/22 | 05/04/22 |
| Most Recent Dividend | N/A | 0.540 on 03/31/22 | 1.940 on 05/16/22 | 0.730 on 03/14/22 | N/A |
| Next Ex-Dividends Date | N/A | 03/31/22 | 05/16/22 | 06/14/22 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 9.84 | 13.86 | 8.63 | 4.21 |
